Genenta Science shares surge 11.19% intraday after announcing transformation to Saentra Forge, strategic consolidator focused on biotech, defense, and national security sectors.

Genenta Science surged 11.19% intraday following its announcement to rebrand as Saentra Forge, a strategic industrial consolidator targeting biotech, defense, and national-security-related technologies. The transformation, detailed in a March 24 press release, positions the company to acquire and scale promising Italian firms in critical sectors, leveraging its Nasdaq listing and capital access. CEO Pierluigi Paracchi emphasized retaining domestic innovation and creating long-term shareholder value through disciplined acquisitions. The move aligns with recent institutional buying, as 9 hedge funds added shares in Q4 2025, including Citadel and Morgan Stanley. While the company noted no current partnerships for its biopharma asset Temferon, the strategic pivot to high-growth, sovereign-aligned industries and Paracchi’s share purchases signaled confidence, driving the sharp intraday rally.